open access

Vol 8, No 2 (2007): Practical Diabetology
Review articles (submitted)
Published online: 2007-03-02
Get Citation

Glucose abnormalities and hepatitis virus infections

Małgorzata Godziejewska-Zawada
Diabetologia Praktyczna 2007;8(2):50-57.

open access

Vol 8, No 2 (2007): Practical Diabetology
Review articles (submitted)
Published online: 2007-03-02

Abstract

Since the discovery of the hepatitis C virus in 1989, attention has been paid to the possibly association of chronic HCV infection and the development of diabetes. The prevalence of glucose abnormalities and overt diabetes is four to ten times higher than in general population. Some studies has shown that HCV infection or connected with HCV infection hepatic function impairment induces development of insulin resistance which may leads to type 2 diabetes. Till now we still haven`t know the exact mechanisms which leads to glucose abnormalities. The presence of diabetes and hepatic steatosis may enhance fibrosis progression and hepatocellular carcinoma. Interferon which is used to treat HCV infection is reportedly associated with improved glucose tolerance. However, interferon might enhance underlying autoimmunity against beta cells, leading to overt type 1 diabetes. Further clinical researches are awaited in order to show the connection between chronic HCV infection and diabetes and how effectively detect, prevent, and treat HCV-associated type 2 diabetes, which would also slow the progression of hepatitis C itself.

Abstract

Since the discovery of the hepatitis C virus in 1989, attention has been paid to the possibly association of chronic HCV infection and the development of diabetes. The prevalence of glucose abnormalities and overt diabetes is four to ten times higher than in general population. Some studies has shown that HCV infection or connected with HCV infection hepatic function impairment induces development of insulin resistance which may leads to type 2 diabetes. Till now we still haven`t know the exact mechanisms which leads to glucose abnormalities. The presence of diabetes and hepatic steatosis may enhance fibrosis progression and hepatocellular carcinoma. Interferon which is used to treat HCV infection is reportedly associated with improved glucose tolerance. However, interferon might enhance underlying autoimmunity against beta cells, leading to overt type 1 diabetes. Further clinical researches are awaited in order to show the connection between chronic HCV infection and diabetes and how effectively detect, prevent, and treat HCV-associated type 2 diabetes, which would also slow the progression of hepatitis C itself.
Get Citation

Keywords

type 1 diabetes; type 2 diabetes; hepatitic C; HCV

About this article
Title

Glucose abnormalities and hepatitis virus infections

Journal

Clinical Diabetology

Issue

Vol 8, No 2 (2007): Practical Diabetology

Pages

50-57

Published online

2007-03-02

Bibliographic record

Diabetologia Praktyczna 2007;8(2):50-57.

Keywords

type 1 diabetes
type 2 diabetes
hepatitic C
HCV

Authors

Małgorzata Godziejewska-Zawada

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl